Other OTC - Delayed Quote • USD
Histogen Inc. (HSTO)
At close: April 26 at 9:30 AM EDT
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
19.0000
3,769.0000
919.0000
2,059.0000
Cost of Revenue
--
--
220.0000
968.0000
Gross Profit
--
3,769.0000
699.0000
1,091.0000
Operating Expense
12,074.0000
14,412.0000
16,156.0000
12,805.0000
Operating Income
-12,055.0000
-10,643.0000
-15,457.0000
-11,714.0000
Net Non Operating Interest Income Expense
--
-1.0000
-10.0000
-64.0000
Other Income Expense
--
--
458.0000
-7,039.0000
Pretax Income
-12,383.0000
-10,644.0000
-15,009.0000
-18,817.0000
Net Income Common Stockholders
-12,377.0000
-11,109.0000
-14,950.0000
-18,769.0000
Diluted NI Available to Com Stockholders
-12,377.0000
-11,109.0000
-14,950.0000
-18,769.0000
Basic EPS
-2.81
-3.46
-7.79
-41.60
Diluted EPS
-2.81
-3.46
-7.79
-41.60
Basic Average Shares
4,274.6740
3,211.1390
1,918.1760
450.9180
Diluted Average Shares
4,274.6740
3,211.1390
1,918.1760
450.9180
Total Operating Income as Reported
-12,055.0000
-10,643.0000
-15,457.0000
-18,858.0000
Total Expenses
12,074.0000
14,412.0000
16,376.0000
13,773.0000
Net Income from Continuing & Discontinued Operation
-12,377.0000
-10,621.0000
-14,950.0000
-18,769.0000
Normalized Income
-12,054.0000
-10,621.0000
-14,950.0000
-11,625.0000
Interest Expense
--
1.0000
10.0000
64.0000
Net Interest Income
--
-1.0000
-10.0000
-64.0000
EBIT
-12,383.0000
-10,643.0000
-14,999.0000
-18,753.0000
EBITDA
-12,245.0000
-10,503.0000
-14,902.0000
-18,655.0000
Reconciled Cost of Revenue
--
--
220.0000
968.0000
Reconciled Depreciation
138.0000
140.0000
97.0000
98.0000
Net Income from Continuing Operation Net Minority Interest
-12,377.0000
-10,621.0000
-14,950.0000
-18,769.0000
Total Unusual Items Excluding Goodwill
-323.0000
--
--
-7,144.0000
Total Unusual Items
-323.0000
--
--
-7,144.0000
Normalized EBITDA
-11,922.0000
-10,503.0000
-14,902.0000
-11,511.0000
12/31/2020 - 7/25/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TOVX Theriva Biologics, Inc.
0.4195
+2.33%
PULM Pulmatrix, Inc.
2.0400
-1.45%
APVO Aptevo Therapeutics Inc.
0.7061
+3.84%
RNAZ TransCode Therapeutics, Inc.
0.5499
+5.30%
AMPE Ampio Pharmaceuticals, Inc.
0.3210
-8.29%
IMNN Imunon, Inc.
1.4400
0.00%
FWBI First Wave BioPharma, Inc.
2.7400
+0.37%
HEPA Hepion Pharmaceuticals, Inc.
1.3700
+6.20%
NVIVQ InVivo Therapeutics Holdings Co
0.3700
+2.78%
ATXI Avenue Therapeutics, Inc.
6.20
-29.35%